Actuate Therapeutics (ACTU) Treasury Shares (2024 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Treasury Shares of $617236.0 for Q4 2025, up 13.44% year-over-year from $544111.0 in Q4 2024, and up 2964.42% quarter-over-quarter from $20142.0 in Q3 2025.
Actuate Therapeutics (ACTU) Treasury Shares (2024 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Treasury Shares for 2 consecutive years, with $617236.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares rose 13.44% year-over-year to $617236.0; the TTM figure through Dec 2025 stood at $617236.0 (up 13.44% YoY), while the FY2025 annual figure was $617236.0, up 13.44% from the prior year.
- Treasury Shares rose to $617236.0 in Q4 2025 per ACTU's latest filing, from $20142.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $24.7 million in Q2 2024 and bottomed at $20142.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 617,236.00 |
| Dec 31, 2025 | 617,236.00 |
| Sep 30, 2025 | 20,142.00 |
| Sep 30, 2025 | 20,142.00 |
| Jun 30, 2025 | 584,111.00 |
| Jun 30, 2025 | 584,111.00 |
| Mar 31, 2025 | 584,111.00 |
| Mar 31, 2025 | 584,111.00 |
| Dec 31, 2024 | 544,111.00 |
| Dec 31, 2024 | 544,111.00 |
| Sep 30, 2024 | 544,111.00 |
| Sep 30, 2024 | 544,111.00 |
| Jun 30, 2024 | 24.68 Mn |
| Jun 30, 2024 | 24.68 Mn |